PRISM MediaWire - Weekly Press Resume - Dec. 18 to Dec. 22, 2023

22 December 2023

New York, December 22, 2023

SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange

SinglePoint Rings the Opening Bell at Cboe Global Markets Exchange - Prism Media Wire

Phoenix, AZ, December 18, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a renewable solar energy and sustainable solutions provider participated in the iconic opening bell ringing ceremony, Friday December 15th, 2023. The event marked the successful listing of the Company’s common stock on the Cboe BZX Exchange. “It was a pleasure to initiate

MindMed Advances Treatment for Generalized Anxiety Disorder

MindMed Advances Treatment for Generalized Anxiety Disorder - Prism Media Wire

NEW YORK, NY, December 18, 2023 - Biopharmaceutical company, Mind Medicine (Nasdaq: MNMD) has announced positive results from its Phase 2b clinical trial of MM-120 (lysergide d-tartrate) in generalized anxiety disorder (GAD). The trial met its primary endpoint, with MM-120 demonstrating statistically significant and clinically meaningful dose-dependent improvements. Robert Barrow, Chief Executive Officer and Director of MindMed, said, “We

PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday?

PRISM Analysis: Why Did Battalion Oil Shares Soar on Friday? - Prism Media Wire

NEW YORK, NY, December 18, 2023 - Shares in Battalion Oil Corporation (NYSE American: BATL) surged more than 80% on Friday after the company announced it has agreed to be acquired by Fury Resources, Inc. for $9.80 per share in cash, which represents a total transaction value of approximately $450 million. The transaction is expected to close in the

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors - Prism Media Wire

POMPANO BEACH, FLORIDA, December 19, 2023 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed Mr. Patrick Daly to its Board of Directors. Mr. Daly is an award-winning executive leader with a strong track

PPJ Healthcare Enterprises, Inc. signed new Billing Accounts

PPJ Healthcare Enterprises, Inc. signed new Billing Accounts - Prism Media Wire

TAMPA, FLORIDA, December 19, 2023 - PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) has announced today that it closed one billing agreement with a ‘pain management physicians’ group to provide their billing and collections. “We have been successful in providing specialty billing services for over 33 years, and we are very excited to add this

SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split

SinglePoint Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split - Prism Media Wire

Phoenix, AZ, December 19, 2023 - SinglePoint Inc. (Cboe: SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged through its subsidiaries in providing renewable energy solutions and energy-efficient applications to drive better health and living, today announced the closing of its underwritten public offering of 800,000 shares of common stock at a public offering

NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment

NRx Pharmaceuticals Secures IND for Urinary Tract Infection Treatment - Prism Media Wire

New York, December 19, 2023 - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) has been granted FDA clearance for its Investigational New Drug Application (IND) for NRX-101 for the treatment of complicated Urinary Tract infections (cUTI). The company’s shares surged 25% in trading on Monday following the news. Complicated Urinary Tract Infections afflict approximately 3 million Americans each year, and pathogens

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished - Prism Media Wire

-Lipella Granted Two Orphan Drug Designations by FDA- Pittsburgh, PA, December 20, 2023 - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company") a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a publicly traded entity. Based in Pittsburgh, PA, the Company has made substantial strides over the past year, achieving critical

Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership

Buy Now, Pay Later: Affirm Shares Jump on News of Walmart Partnership - Prism Media Wire

New York, December 20, 2023 - Shares in payment network company, Affirm Holdings (Nasdaq: AFRM), jumped more than 15% on Tuesday after the company announced it would expand its partnership with Walmart to offer a Buy Now, Pay Later (BNPL) service at self-checkout kiosks at over 4,500 Walmart stores in the United States. Pat Suh, Affirm’s SVP of Revenue,

Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control

Spooz, Inc. (SPZI) Completes Primary Acquisitions and Change of Control - Prism Media Wire

Spooz Acquired Key JP Energy Assets; Vests Control to John K. Park Clearwater, FL., December 20, 2023 -- Spooz, Inc. (OTC: SPZI) completed the acquisition of key JP Energy assets for vesting control of Spooz, Inc. to John K. Park. Additional assets to be announced later in exchange for vesting control of Spooz, Inc. to

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success

PRISM MarketView: Biotech In Motion – Lipella Pharmaceuticals Celebrates Year of Success - Prism Media Wire

New York, December 20, 2023 - Clinical-stage biotechnology company, Lipella Pharmaceuticals (Nasdaq: LIPO) is celebrating a year of strategic accomplishments on its first anniversary as a public company. Lipella is advancing three clinical indications and has been granted two Orphan Drug Designations by the US Food and Drug Administration (FDA). Today, the company announced it has successfully completed a

PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120%

PRISM BIOTECH IN MOTION: FDA APPROVAL FOR PANBELA THERAPEUTICS PEDIATRIC CANCER DRUG; SHARES JUMP 120% - Prism Media Wire

New York, December 20, 2023 - PRISM MarketView, a leading provider of unbiased market insight and company news, today highlights Panbela Therapeutics, Inc. which has announced that US WorldMeds®1 (USWM) has received FDA approval of its New Drug Application (NDA) for the use of eflornithine as a maintenance therapy for high-risk neuroblastoma patients. In July 2023, Panbela divested

Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com

Clubhouse Media Group, Inc. Announces Separation from Agency to Focus Resources on HoneyDrip.com - Prism Media Wire

LOS ANGELES, December 21, 2023 - Clubhouse Media Group, Inc. (OTC: CMGR) ("CMGR"), a social media firm, today announced that it has terminated its joint venture agreement with The Reiman Agency so that the company can dedicate its time and resources to the development and continued growth of HoneyDrip.com. Honeydrip.com is a digital platform designed

Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial

Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial - Prism Media Wire

New York, December 21, 2023 - Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct a phase 1/2 clinical trial using the company’s innovative StemSpine® treatment known as AlloStem™ (CELZ-201-DDT). Timothy Warbington, CEO of Creative Medical Technology, said, “The FDA’s clearance and IRB approval allowing us to pursue this clinical trial is another milestone event for

SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange

SinglePoint CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange - Prism Media Wire

Successfully Uplisted to Cboe BZX Exchange December 15, 2023 Year to Date Revenue Crossing $30 million Completed $4,000,000 Underwritten Offering Capital Raise Phoenix, AZ, December 21, 2023 - SinglePoint Inc. (Cboe: SING) a leading renewable solar energy and sustainable solutions provider releases shareholder letter overviewing 2023 and Successful listing on Cboe BZX Exchange. Dear Shareholders, As

Palatin Technologies Sells Vyleesi in $171M Transaction

Palatin Technologies Sells Vyleesi in $171M Transaction - Prism Media Wire

New York, December 21, 2023 - Palatin Technologies, Inc. (NYSE American: PTN) has completed the sale of Vyleesi® to Cosette Pharmaceuticals, a US-based, specialty pharmaceutical company, for up to $171 million. Vyleesi is the first and only as-needed FDA-approved treatment for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). Carl Spana, Ph.D., President and Chief Executive Officer

Spooz, Inc. (SPZI) / JP Energy / John K. Park – announce Shareholder Letter

Spooz, Inc. (SPZI) / JP Energy / John K. Park – announce Shareholder Letter - Prism Media Wire

Clearwater, FL., December 21, 2023 -- Spooz, Inc. (OTC: SPZI) announces the release of the following shareholder letter: Dear Spooz Shareholder, By now, you are aware that I recently became the Chairman and CEO of Spooz. I am a 63-year-old Korean businessman and a US Citizen. I received my MBA from Rutgers University 24 years ago

Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start

Ring In The New Year with Traditions and Trades: Cultural Celebrations and Stock Plays for a Prosperous Start - Prism Media Wire

New York, December 21, 2023 - In two weeks, 2023 will be history so consider this your reminder to start figuring out a resolution that likely will be forgotten, by this time next year. New Years is celebrated in a multitude of ways based on geography, culture, or religion. However, unlike other holidays, it is

PRISM Analysis: Why Did CareCloud Shares Jump This Week?

PRISM Analysis: Why Did CareCloud Shares Jump This Week? - Prism Media Wire

New York, December 22, 2023 - Healthcare technology solutions provider, CareCloud, Inc. (Nasdaq: CCLD) has seen a jump in its share price this week. The new momentum is being driven by the company’s financial and operational update, issued on Wednesday, and outlining an attractive roadmap for future growth. Shareholders rewarded CareCloud with a 25.61% increase following Wednesday’s session, and

PRISM Analysis PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40%.png

PRISM Analysis: PetVivo Holdings Achieves Distribution Milestone; Shares Soar 40% - Prism Media Wire

New York, December 22, 2023 - PetVivo Holdings, Inc. (Nasdaq: PETV) has achieved a distribution milestone, reporting a total of 4500 syringes of Spryng™ with OsteoCushion™ technology distributed to veterinarians in the 2023 calendar year. Spryng, the company’s signature product, helps to manage lameness, joint pain and osteoarthritis in horses and small animals. Earlier this month, the company announced the sale

HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment.png

HOOKIPA Stock Jumps Following $21.25M Gilead Equity Investment - Prism Media Wire

New York, December 22, 2023 - Gilead Sciences (Nasdaq: GILD) has purchased 15 million shares of immunotherapeutics company, HOOKIPA Pharma’s (Nasdaq: HOOK), common stock for approximately $21.25 million, at a price of $1.4167 per share. Under the agreement, HOOKIPA is responsible for advancing its HIV program through the completion of a Phase 1b clinical trial. The company’s shares rose 52.65% on Thursday

PRISM MediaWire

Phone: (646) 863-7997

Email: info@prismmediawire.com

Website: https://prismmediawire.com/

Social Media:

Feedback - We would love to hear your thoughts, suggestions, concerns or problems with anything so we can improve!

Get Free Email Updates!